Unlocking the Power of AI in Pharmaceutical Development
We're excited to announce September's Formulation Forum, featuring co-speakers Kevin Bittorf, Ph.D., and Keith Parent on September 25th. Kevin and Keith will detail the power of AI in pharmaceutical development.
Application of Compaction Simulation Technology in the Development of Oral Solid Dosage Forms
Characterization of powder mechanical properties and systematic study of powder compression are critical for guiding formulation and process development, enabling tableting scale-up across product lif...
CPHI Frankfurt 2025
In a world where technology, regulations, and therapeutic modalities evolve by the month, how do biotech teams stay ahead? We' re here to help.Date: October 28-30Location: Messe Frankfurt, Frankfu...
Chiral Separation
More than 70% of drug candidates worldwide are chiral. Typically, for chiral API, only one enantiomer or diasteromer is biologically active or desirable. Therefore, the production of enantiopure compounds or diastereomers is imperative. In the production of small molecule drugs with desired chirality, separation via crystallization can be much more economical and environmentally favorable than chromatography.
Our Partner
We continue to provide our clients with high-quality, innovative, customized and technology-driven solutions to move your molecules to the clinic.
Webinar Series
Case Study 5: Lifecycle Management - Olanzapine - Crystalline Change From Free Acid to Salt
Olanzapine (Fig. 12), a Biopharmaceutics Drug Disposition Classification System (BDDCS) 2 drug (Benet et al. 2011) with poor solubility and high permeability, has been marketed towards treating schizo...
Subscribe to be the first to get the updates!
